Page last updated: 2024-08-16

raloxifene and N-[2-[4-(2-oxo-3H-benzimidazol-1-yl)-1-piperidinyl]ethyl]-2-naphthalenecarboxamide

raloxifene has been researched along with N-[2-[4-(2-oxo-3H-benzimidazol-1-yl)-1-piperidinyl]ethyl]-2-naphthalenecarboxamide in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Armstrong, MD; Arteaga, CL; Brown, HA; Buck, JR; Cho, HP; Criswell, TL; Lindsley, CW; Scott, SA; Selvy, PE; Thomas, AL1
Brown, HA; Brown, KA; Cho, CH; Jung, DI; Larock, RC; Lavieri, RR; Lindsley, CW; O'Reilly, MC; Scott, SA; Spencer, CT1

Other Studies

2 other study(ies) available for raloxifene and N-[2-[4-(2-oxo-3H-benzimidazol-1-yl)-1-piperidinyl]ethyl]-2-naphthalenecarboxamide

ArticleYear
Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness.
    Nature chemical biology, 2009, Volume: 5, Issue:2

    Topics: Breast Neoplasms; Drug Design; Enzyme Inhibitors; Humans; Isoenzymes; Neoplasm Invasiveness; Phospholipase D

2009
Discovery of desketoraloxifene analogues as inhibitors of mammalian, Pseudomonas aeruginosa, and NAPE phospholipase D enzymes.
    ACS chemical biology, 2015, Feb-20, Volume: 10, Issue:2

    Topics: Animals; Cell Line; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Humans; Molecular Structure; Phospholipase D; Pseudomonas aeruginosa; Raloxifene Hydrochloride

2015